Drugs of anesthesia, central nicotinic receptors and Parkinson's disease.

[1]  V. Fodale,et al.  Drugs of anesthesia, central nicotinic receptors and post‐operative cognitive dysfunction , 2003, Acta anaesthesiologica Scandinavica.

[2]  M. O'Neill,et al.  The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. , 2002, Current drug targets. CNS and neurological disorders.

[3]  V. Fodale,et al.  Laudanosine, an atracurium and cisatracurium metabolite. , 2002, European journal of anaesthesiology.

[4]  J. Chad,et al.  The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms. , 1998, European journal of pharmacology.

[5]  C. Okuda,et al.  The interaction of pancuronium and vecuronium with cardiac muscarinic receptors , 1987, Acta anaesthesiologica Scandinavica.

[6]  Dominique Muller,et al.  The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia , 2002, Brain Research Bulletin.

[7]  D. Bertrand,et al.  Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage , 2002, Acta anaesthesiologica Scandinavica.

[8]  K. Fuxe,et al.  Central nicotinic receptors, neurotrophic factors and neuroprotection , 2000, Behavioural Brain Research.

[9]  G. Hall,et al.  Parkinson's disease and anaesthesia. , 2002, British journal of anaesthesia.

[10]  J. Drago,et al.  Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice , 2001, British journal of pharmacology.

[11]  V. Fodale,et al.  The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite , 2003, Acta anaesthesiologica Scandinavica.

[12]  V. Fodale,et al.  The inhibition of central nicotinic nAch receptors is the possible cause of prolonged cognitive impairment after anesthesia. , 2003, Anesthesia and analgesia.